Impact of Fingolimod Adherence on Outcomes

Condition:   Multiple Sclerosis Intervention:   Drug: Fingolimod Sponsor:   Novartis Pharmaceuticals Completed

Source: ClinicalTrials.gov - December 2, 2021 Category: Research Source Type: clinical trials